Compare H1B visa sponsorship data between Goldman Sachs and Sciegen Pharmaceuticals. See how they stack up on salary, approval rates, and more.
Key Statistics Comparison
Total H1B Filings
+4919%
14,154
Goldman Sachs
282
Sciegen Pharmaceuticals
Median Salary
+52.6%
$113,200
Goldman Sachs
$74,175
Sciegen Pharmaceuticals
Approval Rate
99.0%
Goldman Sachs
100.0%
Sciegen Pharmaceuticals
Years Sponsoring
+20.0%
18
Goldman Sachs
15
Sciegen Pharmaceuticals
Historical Trends
H1B Filings Over Time
Goldman Sachs
Sciegen Pharmaceuticals
Median Salary Trend
Goldman Sachs
Sciegen Pharmaceuticals
Where & What They Hire
Top H1B Job Categories
Goldman Sachs
Software Developers 131 filings
Financial and Investment Analysts 83 filings
Financial Quantitative Analysts 73 filings
Financial Risk Specialists 72 filings
Business Intelligence Analysts 63 filings
Sciegen Pharmaceuticals
Chemists 20 filings
Industrial Engineers 3 filings
Database Administrators 1 filings
Natural Sciences Managers 1 filings
Validation Engineers 1 filings
Top H1B Work Locations
Goldman Sachs
Dallas, TX 249 filings
Salt Lake City, UT 209 filings
New York, NY 169 filings
Jersey City, NJ 14 filings
New York, NY 12 filings
Sciegen Pharmaceuticals
Hauppauge, NY 26 filings
Hauppauge, NY 2 filings
Year-by-Year Breakdown
| Year | Goldman Sachs | Sciegen Pharmaceuticals | ||||
|---|---|---|---|---|---|---|
| Filings | Salary | Approval | Filings | Salary | Approval | |
| FY2025 | 731 | $113,200 | 99.0% | 28 | $74,175 | 100.0% |
| FY2024 | 310 | $145,000 | 100.0% | 4 | $92,250 | 100.0% |
| FY2023 | 186 | $150,000 | 100.0% | 3 | $80,000 | 100.0% |
| FY2022 | 306 | $149,000 | 100.0% | 6 | $103,350 | 100.0% |
| FY2021 | 527 | $125,000 | 100.0% | 6 | $61,909 | 100.0% |
| FY2020 | 249 | $138,000 | 100.0% | 1 | $77,000 | 100.0% |
| FY2019 | 1,726 | $115,000 | 98.7% | 42 | $64,400 | 100.0% |
| FY2018 | 1,779 | $110,000 | 98.7% | 31 | $65,000 | 100.0% |
| FY2017 | 1,085 | $103,600 | 99.0% | 47 | $48,000 | 100.0% |
| FY2016 | 1,086 | $105,050 | 98.2% | 31 | $46,000 | 100.0% |
Showing most recent 10 years of 18 total
Frequently Asked Questions
- Which company pays higher H1B salaries, Goldman Sachs or Sciegen Pharmaceuticals?
- Goldman Sachs pays higher H1B salaries with a median of $113,200 compared to Sciegen Pharmaceuticals's $74,175.
- Which company sponsors more H1B visas, Goldman Sachs or Sciegen Pharmaceuticals?
- Goldman Sachs has sponsored more H1B visas with 14,154 total filings compared to Sciegen Pharmaceuticals's 282.
- How do Goldman Sachs and Sciegen Pharmaceuticals H1B approval rates compare?
- Goldman Sachs has a 99.0% H1B approval rate while Sciegen Pharmaceuticals has 100.0%. Sciegen Pharmaceuticals has a higher approval rate.